Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 25;14:267–271. doi: 10.2147/IJGM.S290118

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Fan et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Changes in proportions of therapies use for COVID-19 from April to July in hospitalized patients in the US. Among 21,736 COVID-19 hospitalized patients in April in our study, the proportions of therapies use were 52.2% for Hydroxychloroquine (HCQ) with and without Azithromycin (AZM), 0.4% for remdesivir, 1.6% for convalescent plasma, 4.7% for dexamethasone, and 87.0% for anticoagulants. The line graph displays the differences in the proportions of these selected therapies use in May, June, or July compared to April. Proportions of therapies use in the overall study population and in patients admitted to the intensive care unit (ICU) from April to July are shown in Supplementary Tables 2 and 3.